Amicus Therapeutics Inc (NASDAQ:FOLD) At $6.11: Does It Look Expensive?
In recent trading session, Amicus Therapeutics Inc (NASDAQ:FOLD) saw 0.97 million shares changing hands at last check today with its beta currently measuring 0.53. Company’s
In recent trading session, Amicus Therapeutics Inc (NASDAQ:FOLD) saw 0.97 million shares changing hands at last check today with its beta currently measuring 0.53. Company’s
During the last session, Amicus Therapeutics Inc (NASDAQ:FOLD)’s traded shares were 5.5 million, with the beta value of the company hitting 0.54. At the end
In the latest trading session,, 1.61 million Amicus Therapeutics Inc (NASDAQ:FOLD) shares changed hands as the company’s beta touched 0.54. With the company’s most recent
During the last session, Amicus Therapeutics Inc (NASDAQ:FOLD)’s traded shares were 5.66 million, with the beta value of the company hitting 0.64. At the end
In the latest trading session,, 0.55 million Amicus Therapeutics Inc (NASDAQ:FOLD) shares changed hands as the company’s beta touched 0.65. With the company’s most recent
© 2024, Powered by Smart TechOne